US Veterinary Diagnostics Market

The US veterinary diagnostics market is projected to reach USD 3.74 billion by 2031, growing from USD 2.41 billion in 2026 at a CAGR of 9.1% during the forecast period.

Key factors driving market growth include the rising population of companion animals, the rising incidence of infectious diseases, increased focus on early disease diagnosis, and increasing adoption of companion animals as pets. Additionally, technological advancements in veterinary diagnostic technologies and the cost-effective services offered by veterinary diagnostic end users are expected to fuel the market adoption during the forecast period.

To know about the assumptions considered for the study download the pdf brochure

The prominent players in the US veterinary diagnostics market include IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Thermo Fisher Scientific Inc. (US), Antech Diagnostics, Inc. (US), bioMérieux (France), Neogen Corporation (US), Bio-Rad Laboratories, Inc. (US), Virbac (France), FUJIFILM Holdings Corporation (Japan), and Shenzhen Mindray Animal Medical Technology Co., LTD. (China). These players have been adopting growth strategies, both organic and inorganic, including the introduction of products, the formation of strategic partnerships, and penetration into emerging markets. These initiatives are aimed at enhancing their market share and diversifying their portfolios.

IDEXX LABORATORIES, INC. (US)

IDEXX is a leader in US veterinary diagnostics and software, catering to the companion animal practices, livestock, and poultry markets. The company’s products include in-clinic analyzers like Catalyst One (chemistry), ProCyte Dx (hematology), SNAP tests (rapid immunoassays), and the VETLAB Station for integrated diagnostics. IDEXX’s focus is on enhancing its cloud-based VetConnect PLUS platform, enabling real-time diagnostic results, analytics, and AI-driven insights. The company’s Vetscan Imagyst, powered by AI, supports cytology, fecal, and dermatology diagnostics. It invests heavily in R&D, allocating over 6% of annual revenue to innovation focused on expanding diagnostic precision and integrating digital workflows for faster decision-making.

ZOETIS SERVICES LLC (US)

Zoetis operates as one of the broadest portfolios in the US veterinary diagnostics space, catering to the companion animals and livestock sectors. Its diagnostics business includes point-of-care instruments, such as the VETSCAN series, VETSCAN VS2, VETSCAN Imagyst, and VETSCAN SA for hematology, chemistry, and AI-assisted slide analysis. In 2024, Zoetis launched the VETSCAN OptiCell, an AI-powered, cartridge-based hematology analyzer that delivers CBC results in under 5 minutes. Zoetis is also focused on advancing R&D in molecular & biomarker-based tests. It is also focused on expanding the capabilities of its Imagyst platform to support microbiology & oncology diagnostics. In January 2024, the company added an AI Urine sediment analysis program to its Imagyst platform. In June 2025, it launched AI Masses, an AI-powered analysis technology to be integrated into the Vetscan Imagyst analyzer. The company invests significantly in AI and digital innovation to streamline veterinary workflows and improve diagnostic speed & accuracy across species.

THERMO FISHER SCIENTIFIC INC. (US)

Thermo Fisher Scientific’s US veterinary diagnostics product portfolio covers molecular diagnostics, ELISA kits, and PCR-based tests, catering to the livestock & research animal sectors and supporting companion animal diagnostics. The company’s VetMAX product line provides real-time PCR solutions for detecting diseases, such as avian influenza, bovine viral diarrhea (BVD), and African swine fever. Thermo Fisher is known for its high-throughput & precise qPCR platforms like QuantStudio and Applied Biosystems instruments used in veterinary labs. The company invests heavily in R&D to develop custom assay kits and improve sample-to-answer turnaround times, focusing on zoonotic disease monitoring and biosecurity diagnostics. Collaborating with government and food safety agencies has expanded its global animal health surveillance role.

Market Ranking

The top five companies in the veterinary diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Thermo Fisher Scientific Inc. (US), Antech Diagnostics, Inc. (US), and bioMérieux (France). Due to innovation, IDEXX Laboratories, Inc. (US) excels in the market with a robust & varied product portfolio encompassing advanced veterinary diagnostic instruments and diagnostic test kits. Zoetis Services LLC (US) leverages its R&D prowess and various organic & inorganic growth strategies to uphold a formidable market presence. Thermo Fisher Scientific Inc. (US) strengthens its competitive edge through its robust R&D programs and an increasingly expansive global footprint. Antech Diagnostics, Inc. (US) enhances its market position by diversifying its product range and focusing on increased AI integration across its products. bioMérieux (France) capitalizes on innovation and technological advancements in the veterinary diagnostic market to solidify its presence.

Related Reports:

US Veterinary Diagnostics Market by Application (Infectious, Bacterial, Endocrine), Technology (Immunodiagnostic, PCR, ELISA, Lateral Flow), Product (Consumables, Instruments), Animal (Dog, Cat, Cattle), End User (POC, Veterinary Labs) - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com